These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26008169)

  • 1. New challenges in the diagnosis and management of cystic fibrosis.
    Levy H; Farrell PM
    J Pediatr; 2015 Jun; 166(6):1337-41. PubMed ID: 26008169
    [No Abstract]   [Full Text] [Related]  

  • 2. Question 7: For an infant with an equivocal sweat chloride following newborn screening, how likely is a diagnosis of cystic fibrosis?
    Groves T; Robinson P; Fitzgerald DA
    Paediatr Respir Rev; 2016 Sep; 20():48-50. PubMed ID: 26724140
    [No Abstract]   [Full Text] [Related]  

  • 3. Sweat testing in newborns positive to neonatal screening for cystic fibrosis.
    Taccetti G; Festini F; Braccini G; Campana S; de Martino M
    Arch Dis Child Fetal Neonatal Ed; 2004 Sep; 89(5):F463-4. PubMed ID: 15321972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protracted neonatal hypertrypsinogenaemia, normal sweat chloride, and cystic fibrosis.
    Castellani C; Tamanini A; Mastella G
    Arch Dis Child; 2000 Jun; 82(6):481-2. PubMed ID: 10833182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening for cystic fibrosis.
    Hayes D
    South Med J; 2006 Apr; 99(4):403. PubMed ID: 16634253
    [No Abstract]   [Full Text] [Related]  

  • 6. A continuing role for sweat testing in an era of newborn screening for cystic fibrosis.
    Kirk JM
    Clin Biochem; 2011 May; 44(7):487-488. PubMed ID: 22036339
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence based guidelines for the performance of the sweat test for the investigation of cystic fibrosis in the UK.
    Baumer JH
    Arch Dis Child; 2003 Dec; 88(12):1126-7. PubMed ID: 14670787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sweat chloride testing: controversies and issues.
    Kharrazi M; Milla C; Wine J
    Lancet Respir Med; 2016 Aug; 4(8):605-607. PubMed ID: 27511631
    [No Abstract]   [Full Text] [Related]  

  • 9. [French guidelines for sweat test practice and interpretation for cystic fibrosis neonatal screening].
    Sermet-Gaudelus I; Munck A; Rota M; Roussey M; Feldmann D; Nguyen-Khoa T;
    Arch Pediatr; 2010 Sep; 17(9):1349-58. PubMed ID: 20719482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Devil in the detail of newborn screening for cystic fibrosis.
    Doull I
    Arch Dis Child; 2019 Oct; 104(10):938-940. PubMed ID: 30389674
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical evaluation of the Nanoduct sweat test system in the diagnosis of cystic fibrosis after newborn screening.
    Vernooij-van Langen A; Dompeling E; Yntema JB; Arets B; Tiddens H; Loeber G; Dankert-Roelse J
    Eur J Pediatr; 2015 Aug; 174(8):1025-34. PubMed ID: 25678232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sweat testing infants detected by cystic fibrosis newborn screening.
    Parad RB; Comeau AM; Dorkin HL; Dovey M; Gerstle R; Martin T; O'Sullivan BP
    J Pediatr; 2005 Sep; 147(3 Suppl):S69-72. PubMed ID: 16202787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of immediate telephone follow-up with providers on sweat chloride test timing after cystic fibrosis newborn screening identifies a single mutation.
    La Pean A; Farrell MH; Eskra KL; Farrell PM
    J Pediatr; 2013 Mar; 162(3):522-9. PubMed ID: 23102590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sweat testing: review of technical requirements].
    Rota M; Nguyen-Khoa T; Marchand M; Feldmann D; Dumont J; Khalfon D; Vassault A; Borgard JP;
    Ann Biol Clin (Paris); 2008; 66(2):221-7. PubMed ID: 18390434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of cystic fibrosis after newborn screening: the Australasian experience--twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group.
    Massie J; Clements B;
    Pediatr Pulmonol; 2005 May; 39(5):440-6. PubMed ID: 15704202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of cystic fibrosis in the kindred of an infant with CFTR-related metabolic syndrome: importance of follow-up that includes monitoring sweat chloride concentrations over time.
    Williams SN; Nussbaum E; Chin TW; Do PC; Singh KE; Randhawa I
    Pediatr Pulmonol; 2014 Mar; 49(3):E103-8. PubMed ID: 24535988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed diagnosis of cystic fibrosis in children with a rare genotype (delta F508/R117H).
    Fitzgerald D; Van Asperen P; Henry R; Waters D; Freelander M; Wilson M; Wilcken B; Gaskin K
    J Paediatr Child Health; 1995 Jun; 31(3):168-71. PubMed ID: 7669372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sweat chloride testing in infants identified as heterozygote carriers by newborn screening.
    Soultan ZN; Foster MM; Newman NB; Anbar RD
    J Pediatr; 2008 Dec; 153(6):857-9. PubMed ID: 19014821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of quantitative sweat chloride methods after positive newborn screen for cystic fibrosis.
    Laguna TA; Lin N; Wang Q; Holme B; McNamara J; Regelmann WE
    Pediatr Pulmonol; 2012 Aug; 47(8):736-42. PubMed ID: 22786625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two sweat test systems for the diagnosis of cystic fibrosis in newborns.
    Rueegg CS; Kuehni CE; Gallati S; Jurca M; Jung A; Casaulta C; Barben J;
    Pediatr Pulmonol; 2019 Mar; 54(3):264-272. PubMed ID: 30609259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.